Impact of Supply Chain Disruptions
The Atorvastatin API Market faced significant challenges during the COVID-19 pandemic due to global supply chain disruptions. Lockdowns, port delays, and raw material shortages slowed API production and delivery.These disruptions highlighted the risks of over-reliance on a few manufacturing hubs, prompting pharmaceutical companies to diversify sourcing and build local production capabilities. Many are now adopting dual-sourcing strategies and maintaining larger safety stocks to ensure uninterrupted supply.Supply chain resilience has become a top priority, with blockchain-based traceability, predictive analytics, and AI-powered demand forecasting helping to mitigate future risks.
1 View